Risk of complications such as infections and reruptures within 12 months after initiation of treatment. [ Time Frame: The patients are examined at baseline and after 6 and 12 months. ] [ Designated as safety issue: No ]Secondly, we want to compare the risk of complications such as infections and reruptures.